What is eMed?
Founded in 2020, eMed operates at the forefront of digital health, offering a comprehensive telehealth platform. Its core offering is a digital point-of-care system designed for at-home health testing. This platform is supervised and guided online by eMed Certified Guides, ensuring professional oversight. By embracing quantitative medicine, eMed aims to deliver prescribed tests and treatments directly to individuals, thereby driving improved and more cost-effective health outcomes. The company's focus on accessible, technology-driven healthcare positions it as a key player in the evolving health tech landscape.
How much funding has eMed raised?
eMed has raised a total of $200M across 1 funding round:
Series A
$200M
Series A (2026): $200M with participation from Aon
Key Investors in eMed
Aon
Aon is a global leader in risk management, insurance, and HR solutions. Their involvement suggests a strategic interest in the operational and risk aspects of eMed's healthcare delivery model, potentially offering expertise in scaling and managing complex health services.
What's next for eMed?
With the recent influx of major strategic investment, eMed is poised for significant expansion and further development of its telehealth services. The substantial capital will likely be directed towards enhancing its digital platform, broadening its service offerings, and potentially scaling its operations to reach a wider patient demographic. This funding round, characterized as enterprise-level, suggests a strategic focus on solidifying its market position and advancing its quantitative medicine approach to healthcare delivery. Future initiatives may include further integration of AI and data analytics to personalize patient care and optimize health outcomes.
See full eMed company page
